Author:
Nacasaki Silvestre Renata,Moço Pablo Diego,Picanço-Castro Virgínia
Reference20 articles.
1. Park JH, Brentjens RJ (2010) Adoptive immunotherapy for B-cell malignancies with autologous chimeric antigen receptor modified tumor targeted T cells. Discov Med 9(47):277–288
2. Schriever F, Freedman AS, Freeman G, Messner E, Lee G, Daley J, Nadler LM (1989) Isolated human follicular dendritic cells display a unique antigenic phenotype. J Exp Med 169(6):2043–2058
3. Scheuermann RH, Racila E (1995) CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy. Leuk Lymphoma 18(5-6):385–397.
https://doi.org/10.3109/10428199509059636
4. Uckun FM, Jaszcz W, Ambrus JL, Fauci AS, Gajl-Peczalska K, Song CW, Wick MR, Myers DE, Waddick K, Ledbetter JA (1988) Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins. Blood 71(1):13–29
5. Tumaini B, Lee DW, Lin T, Castiello L, Stroncek DF, Mackall C, Wayne A, Sabatino M (2013) Simplified process for the production of anti–CD19-CAR–engineered T cells. Cytotherapy 15(11):1406–1415.
https://doi.org/10.1016/j.jcyt.2013.06.003
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献